SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3/A - Registration statement by foreign private issuers: [Amend]
SEC Accession No. 0001144204-14-020274
Filing Date
2014-04-02
Accepted
2014-04-02 17:01:19
Documents
12

Document Format Files

Seq Description Document Type Size
1 FORM F-3/A v373626_f3a.htm F-3/A 876596
2 GRAPHIC tlogo.jpg GRAPHIC 7932
3 EXHIBIT 5.1 v373626_ex5-1.htm EX-5.1 14502
4 EXHIBIT 10.1 v373626_ex10-1.htm EX-10.1 63481
5 EXHIBIT 10.2 v373626_ex10-2.htm EX-10.2 1492521
6 EXHIBIT 23.1 v373626_ex23-1.htm EX-23.1 3433
7 EXHIBIT 23.2 v373626_ex23-2.htm EX-23.2 3534
8 EXHIBIT 23.3 v373626_ex23-3.htm EX-23.3 3464
9 GRAPHIC tlogo5-1.jpg GRAPHIC 6925
10 GRAPHIC tex10-2pg2.jpg GRAPHIC 15576
11 GRAPHIC tfooter.jpg GRAPHIC 84022
12 GRAPHIC tlogoex.jpg GRAPHIC 4212
  Complete submission text file 0001144204-14-020274.txt   2622705
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000
Type: F-3/A | Act: 33 | File No.: 333-194338 | Film No.: 14738972
SIC: 2834 Pharmaceutical Preparations